{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:08:17Z","timestamp":1791839297274,"version":"4.3.4"},"reference-count":127,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ensuring the proper amount of water inside the body is essential for survival. One of the key factors in the maintenance of body water balance is water reabsorption in the collecting ducts of the kidney, a process that is regulated by aquaporin-2 (AQP2). AQP2 is a channel that is exclusively selective for water molecules and impermeable to ions or other small molecules. Impairments of AQP2 result in various water balance disorders, including nephrogenic diabetes insipidus (NDI), which is a disease characterized by a massive loss of water through the kidney and consequent severe dehydration. Dysregulation of AQP2 is also a cause of water retention with hyponatremia in heart failure, hepatic cirrhosis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Antidiuretic hormone vasopressin is an upstream regulator of AQP2. Its binding to the vasopressin V2 receptor promotes AQP2 targeting to the apical membrane and thus enables water reabsorption. Tolvaptan, a vasopressin V2 receptor antagonist, is effective and widely used for water retention with hyponatremia. However, there are no studies showing improvement in hard outcomes or long-term prognosis. A possible reason is that vasopressin receptors have many downstream effects other than AQP2 function. It is expected that the development of drugs that directly target AQP2 may result in increased treatment specificity and effectiveness for water balance disorders. This review summarizes recent progress in studies of AQP2 and drug development challenges for water balance disorders.<\/jats:p>","DOI":"10.3390\/ijms222312950","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"12950","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Updates and Perspectives on Aquaporin-2 and Water Balance Disorders"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-4233","authenticated-orcid":false,"given":"Yumi","family":"Noda","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nitobe Memorial Nakano General Hospital, Tokyo 164-8607, Japan"},{"name":"Department of Nephrology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cellular and Structural Physiology Laboratory, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"ref_1","unstructured":"Coffman, T.M., Falk., R.J., Molitoris, B.A., Neilson, E.G., and Schrier, R.W. (2012). Regulation of water balance: Urine concentration and dilution. Schrier\u2019s Diseases of the Kidney, Lippincott Williams & Wilkins. [9th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/361549a0","article-title":"Cloning and expression of apical membrane water channel of rat kidney collecting tubule","volume":"361","author":"Fushimi","year":"1993","journal-title":"Nature"},{"key":"ref_3","first-page":"F461","article-title":"Aquaporins: A family of water channel proteins","volume":"265","author":"Agre","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1172\/JCI117079","article-title":"Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct","volume":"93","author":"Sasaki","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneph.2009.231","article-title":"Aquaporins in kidney pathophysiology","volume":"6","author":"Noda","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10157-013-0878-5","article-title":"Dynamic regulation and dysregulation of the water channel aquaporin-2: A common cause of and promising therapeutic target for water balance disorders","volume":"18","author":"Noda","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12565-016-0325-2","article-title":"The distribution and function of aquaporins in the kidney: Resolved and unresolved questions","volume":"92","author":"Matsuzaki","year":"2017","journal-title":"Anat. Sci. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbamem.2006.03.004","article-title":"Regulation of aquaporin-2 trafficking and its binding protein complex","volume":"1758","author":"Noda","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/357336a0","article-title":"Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus","volume":"357","author":"Lolait","year":"1992","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"ref_11","first-page":"F823","article-title":"Vasopressin effects on urea and H2O transport in inner medullary collecting duct subsegments","volume":"253","author":"Sands","year":"1987","journal-title":"Am. J. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1681\/ASN.2014020148","article-title":"Short-term functional adaptation of aquaporin-1 surface expression in the proximal tubule, a component of glomerulotubular balance","volume":"26","author":"Pohl","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1016\/j.celrep.2019.05.097","article-title":"Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune Disease","volume":"27","author":"Ciappelloni","year":"2019","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2020.03.037","article-title":"Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema","volume":"181","author":"Kitchen","year":"2020","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chivasso, C., Hagstr\u00f6mer, C.J., Rose, K.L., Lhotellerie, F., Leblanc, L., Wang, Z., Moscato, S., Chevalier, C., Zindy, E., and Martin, M. (2021). Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sj\u00f6gren\u2019s Syndrome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179213"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"F389","DOI":"10.1152\/ajprenal.00204.2021","article-title":"Bayesian identification of candidate transcription factors for the regulation of Aqp2 gene expression","volume":"321","author":"Kikuchi","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1523-1755.2001.00965.x","article-title":"Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis","volume":"60","author":"Saito","year":"2001","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E8875","DOI":"10.1073\/pnas.1709123114","article-title":"Systems-level identification of PKA-dependent signaling in epithelial cells","volume":"114","author":"Isobe","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbrc.2017.06.162","article-title":"Ser-261 phospho-regulation is involved in pS256 and pS269-mediated aquaporin-2 apical translocation","volume":"490","author":"Yui","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s10157-020-01899-4","article-title":"Phosphorylation profile of human AQP2 in urinary exosomes by LC-MS\/MS phosphoproteomic analysis","volume":"24","author":"Sakai","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1096\/fj.02-0870fje","article-title":"Ser-256 phosphorylation dynamics of aquaporin 2 during maturation from the endoplasmic reticulum to the vesicular compartment in renal cells","volume":"17","author":"Procino","year":"2003","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1074\/jbc.M207525200","article-title":"The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel","volume":"277","author":"Savelkoul","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1172\/JCI9594","article-title":"Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells","volume":"106","author":"Bouley","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00337.2004","article-title":"Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)","volume":"288","author":"Bouley","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1113\/JP277024","article-title":"Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation","volume":"597","author":"Cheung","year":"2019","journal-title":"J. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00424-007-0371-7","article-title":"Calcium signaling in vasopressin-induced aquaporin-2 trafficking","volume":"456","author":"Balasubramanian","year":"2008","journal-title":"Pflug. Arch."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"C1606","DOI":"10.1152\/ajpcell.00588.2005","article-title":"Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress","volume":"292","author":"Li","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","article-title":"A second canon: Functions and mechanisms of beta-catenin-independent Wnt signaling","volume":"5","author":"Veeman","year":"2003","journal-title":"Dev. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13636","DOI":"10.1038\/ncomms13636","article-title":"Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway","volume":"7","author":"Ando","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"183573","DOI":"10.1016\/j.bbamem.2021.183573","article-title":"The effects of trifluoperazine on brain edema, aquaporin-4 expression and metabolic markers during the acute phase of stroke using photothrombotic mouse model","volume":"1863","author":"Sylvain","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41583-021-00514-z","article-title":"Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis","volume":"22","author":"Salman","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Salman, M.M., Kitchen, P., Halsey, A., Wang, M.X., Tornroth-Horsefield, S., Conner, A.C., Badaut, J., Iliff, J.J., and Bill, R.M. (2021). Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain, awab311.","DOI":"10.1093\/brain\/awab311"},{"key":"ref_33","first-page":"F978","article-title":"Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats","volume":"274","author":"Sands","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1523-1755.2004.66036.x","article-title":"Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells","volume":"66","author":"Procino","year":"2004","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1242\/jcs.168096","article-title":"Negative feedback from CaSR signaling to aquaporin-2 sensitizes vasopressin to extracellular Ca2","volume":"128","author":"Ranieri","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ranieri, M. (2019). Renal Ca2+ and Water handling in response to calcium sensing receptor signaling: Physiopathological aspects and role of CaSR-regulated microRNAs. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215341"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00424-007-0404-2","article-title":"The role of actin remodeling in the trafficking of intracellular vesicles, transporters, and channels: Focusing on aquaporin-2","volume":"456","author":"Noda","year":"2008","journal-title":"Pflug. Arch."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0079-6123(08)00442-1","article-title":"Actin-binding channels","volume":"170","author":"Noda","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1242\/jcs.00640","article-title":"The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho","volume":"116","author":"Tamma","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00418-005-0010-3","article-title":"Differential regulation of AQP2 trafficking in endosomes by microtubules and actin filaments","volume":"124","author":"Tajika","year":"2005","journal-title":"Histochem. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1681\/ASN.2005020190","article-title":"Bradykinin signaling counteracts cAMP-elicited aquaporin 2 translocation in renal cells","volume":"16","author":"Tamma","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.febslet.2004.05.021","article-title":"Aquaporin-2 trafficking is regulated by PDZ-domain containing protein SPA-1","volume":"568","author":"Noda","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1254\/jphs.FMJ04004X2","article-title":"Molecular mechanisms and drug development in aquaporin water channel diseases: Molecular mechanism of water channel aquaporin-2 trafficking","volume":"96","author":"Noda","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.imlet.2004.01.004","article-title":"Specific recruitment of SPA-1 to the immunological synapse: Involvement of actin-bundling protein actinin","volume":"92","author":"Harazaki","year":"2004","journal-title":"Immunol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1158\/0008-5472.CAN-06-1346","article-title":"Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model","volume":"66","author":"Kometani","year":"2006","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/323643","article-title":"Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus","volume":"69","author":"Kuwahara","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1523-1755.2005.00654.x","article-title":"The C-terminal tail of aquaporin-2 determines apical trafficking","volume":"68","author":"Kuwahara","year":"2005","journal-title":"Kidney Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbrc.2005.03.079","article-title":"Identification of a multiprotein \u201cmotor\u201d complex binding to water channel aquaporin-2","volume":"330","author":"Noda","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0854.2006.00508.x","article-title":"A Role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle","volume":"8","author":"Nedvetsky","year":"2007","journal-title":"Traffic"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"49026","DOI":"10.1074\/jbc.M408565200","article-title":"Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct","volume":"279","author":"Chou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"F600","DOI":"10.1152\/ajprenal.00431.2019","article-title":"CRISPR-Cas9\/phosphoproteomics identifies multiple noncanonical targets of myosin light chain kinase","volume":"318","author":"Isobe","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"F179","DOI":"10.1152\/ajprenal.00015.2021","article-title":"Actin-related protein 2\/3 complex plays a critical role in the aquaporin-2 exocytotic pathway","volume":"321","author":"Liu","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Holst, M.R., Gammelgaard, L., Aaron, J., Login, F.H., Rajkumar, S., Hahn, U., and Nejsum, L.N. (2021). Regulated exocytosis: Renal Aquaporin-2 3D Vesicular Network Organization and Association with F-actin. Am. J. Physiol. Cell Physiol.","DOI":"10.1152\/ajpcell.00255.2021"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/302253a0","article-title":"Vasopressin stimulates formation of coated pits in rat kidney collecting ducts","volume":"302","author":"Brown","year":"1983","journal-title":"Nature"},{"key":"ref_55","first-page":"F998","article-title":"Aquaporin-2 localization in clathrin-coated pits: Inhibition of endocytosis by dominant-negative dynamin","volume":"282","author":"Sun","year":"2002","journal-title":"Am. J. Physiol."},{"key":"ref_56","first-page":"F233","article-title":"Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2","volume":"286","author":"Lu","year":"2004","journal-title":"Am. J. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28721","DOI":"10.1074\/jbc.M611101200","article-title":"Heat shock protein 70 interacts with aquaporin-2 (AQP2) and regulates its trafficking","volume":"282","author":"Lu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1073\/pnas.0604073103","article-title":"Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel","volume":"103","author":"Kamsteeg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1681\/ASN.2017050526","article-title":"CHIP Regulates Aquaporin-2 Quality Control and Body Water Homeostasis","volume":"29","author":"Wu","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbrc.2004.07.195","article-title":"Water channel aquaporin-2 directly binds to actin","volume":"322","author":"Noda","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1042\/BC20040120","article-title":"Trafficking mechanism of water channel aquaporin-2","volume":"97","author":"Noda","year":"2005","journal-title":"Biol. Cell."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.200709177","article-title":"Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking","volume":"182","author":"Noda","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1074\/jbc.270.18.10384","article-title":"cAMP-dependent phosphorylation stimulates water permeability of aquaporin-collecting duct water channel protein expressed in Xenopus oocytes","volume":"270","author":"Kuwahara","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"F649","DOI":"10.1152\/ajprenal.90682.2008","article-title":"Role of multiple phosphorylation sites in the COOH-terminal tail of aquaporin-2 for water transport: Evidence against channel gating","volume":"296","author":"Moeller","year":"2009","journal-title":"Am. J. Physiol Ren. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"40777","DOI":"10.1074\/jbc.M110.151928","article-title":"Phosphorylation of aquaporin-2 regulates its water permeability","volume":"285","author":"Eto","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ndt\/gfh677","article-title":"Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin","volume":"20","author":"Kasono","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1113\/expphysiol.2008.042663","article-title":"Hypotonicity reduces the activity of murine aquaporin-2 promoter induced by dibutyryl cAMP","volume":"93","author":"Saito","year":"2008","journal-title":"Exp. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"26643","DOI":"10.1074\/jbc.M801071200","article-title":"Acute hypertonicity alters aquaporin-2 trafficking and induces a MAP kinase-dependent accumulation at the plasma membrane of renal epithelial cells","volume":"283","author":"Hasler","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1074\/jbc.M207339200","article-title":"Hypertonicity is involved in redirecting the aquaporin-2 water channel into the basolateral, instead of the apical, plasma membrane of renal epithelial cells","volume":"278","author":"Breton","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-7793.2001.0003g.x","article-title":"Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD)","volume":"532","author":"Okada","year":"2001","journal-title":"J. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/en.2006-1277","article-title":"Hypotonicity induces aquaporin-2 internalization and cytosol-to-membrane translocation of ICln in renal cells","volume":"148","author":"Tamma","year":"2007","journal-title":"Endocrinology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.biocel.2009.07.017","article-title":"Aquaporin-2 regulates cell volume recovery via tropomyosin","volume":"41","author":"Li","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1002\/humu.21082","article-title":"p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation","volume":"30","author":"Savelkoul","year":"2009","journal-title":"Hum. Mutat."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2005010104","article-title":"Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus","volume":"16","author":"Savelkoul","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00424-007-0364-6","article-title":"Missorting of the Aquaporin-2 mutant E258K to multivesicular bodies\/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258","volume":"455","author":"Kamsteeg","year":"2008","journal-title":"Pflug. Arch."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1523-1755.2003.00049.x","article-title":"Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 C-terminus mutations","volume":"64","author":"Asai","year":"2003","journal-title":"Kidney Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1073\/pnas.0602331103","article-title":"Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation","volume":"103","author":"Sohara","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Rossier","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"F642","DOI":"10.1152\/ajprenal.00287.2004","article-title":"Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria","volume":"288","author":"Rao","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1681\/ASN.2009060672","article-title":"GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity","volume":"21","author":"Rao","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00266.2003","article-title":"Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI","volume":"286","author":"Christensen","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18311","DOI":"10.1038\/srep18311","article-title":"Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus","volume":"5","author":"Khositseth","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.kint.2016.12.005","article-title":"Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus","volume":"91","author":"Khositseth","year":"2017","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1038\/s41598-020-61882-7","article-title":"Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway","volume":"10","author":"Iervolino","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"F135","DOI":"10.1152\/ajprenal.00113.2019","article-title":"Bilateral ureteral obstruction is rapidly accompanied by ER stress and activation of autophagic degradation of IMCD proteins, including AQP2","volume":"318","author":"Somparn","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semnephrol.2008.03.009","article-title":"Vasopressin and aquaporin 2 in clinical disorders of water homeostasis","volume":"28","author":"Schrier","year":"2008","journal-title":"Semin. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","article-title":"Aquaretic effect of lixivaptan, an oral non-peptide, selective V2 receptor vasopressin antagonist, in the New York Heart Association functional class II and III chronic heart failure patients","volume":"47","author":"Abraham","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.1840210128","article-title":"Increased gene expression of water channel in cirrhotic rat kidneys","volume":"21","author":"Asahina","year":"1995","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.3748\/wjg.v21.i41.11584","article-title":"Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?","volume":"21","author":"Fukui","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0079-6123(08)00445-7","article-title":"Pathophysiological role of aquaporin-2 in impaired water excretion","volume":"170","author":"Ishikawa","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jcem.82.4.3900","article-title":"Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"82","author":"Saito","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1523-1755.2005.00284.x","article-title":"BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199506083322303","article-title":"Urinary excretion of aquaporin-2 in patients with diabetes insipidus","volume":"332","author":"Kanno","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10157-011-0574-2","article-title":"Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method","volume":"16","author":"Sasaki","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1073\/pnas.0403453101","article-title":"Identification and proteomic profiling of exosomes in human urine","volume":"101","author":"Pisitkun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1681\/ASN.V10102165","article-title":"Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure","volume":"10","author":"Martin","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/gut.52.8.1194","article-title":"Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis","volume":"52","author":"Ivarsen","year":"2003","journal-title":"Gut"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00535-015-1143-3","article-title":"Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites","volume":"51","author":"Nakanishi","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_102","first-page":"1665","article-title":"Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects","volume":"86","author":"Ishikawa","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1253\/circj.CJ-14-0244","article-title":"Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure","volume":"78","author":"Imamura","year":"2014","journal-title":"Circ. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2009121267","article-title":"Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration","volume":"22","author":"Bouley","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.2014.10","article-title":"Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice","volume":"86","author":"Procino","year":"2014","journal-title":"Kidney Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1073\/pnas.1509565112","article-title":"Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","article-title":"A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus","volume":"119","author":"Li","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1073\/pnas.1104691108","article-title":"Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus","volume":"108","author":"Olesen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"F935","DOI":"10.1152\/ajprenal.00559.2015","article-title":"The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway","volume":"311","author":"Olesen","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ekir.2020.05.015","article-title":"Treatment of Nephrogenic Diabetes Insipidus Patients with cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability","volume":"5","author":"Hinrichs","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1210\/en.2007-1806","article-title":"Novel treatment for lithiuminduced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene","volume":"149","author":"Suga","year":"2008","journal-title":"Endocrinology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1681\/ASN.2014010118","article-title":"P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus","volume":"26","author":"Zhang","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00001.2011","article-title":"Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase","volume":"301","author":"Li","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cpt.305","article-title":"Simvastatin increases AQP2 urinary excretion in hypercholesterolemic patients: A pleiotropic effect of interest for patients with impaired AQP2 trafficking","volume":"99","author":"Procino","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e13665","DOI":"10.14814\/phy2.13665","article-title":"Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers","volume":"6","author":"Bech","year":"2018","journal-title":"Physiol. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bdi.12973","article-title":"A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users","volume":"23","author":"Beaulieu","year":"2021","journal-title":"Bipolar Disord."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e88409","DOI":"10.1172\/jci.insight.88409","article-title":"Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus","volume":"1","author":"Efe","year":"2016","journal-title":"JCI Insight"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"F749","DOI":"10.1152\/ajprenal.00334.2014","article-title":"Vasopressin-regulated miRNAs and AQP2-targeting miRNAs in kidney collecting duct cells","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.201700412RR","article-title":"CaSR signaling down-regulates AQP2 expression via a novel microRNA pathway in pendrin and NaCl cotransporter knockout mice","volume":"32","author":"Ranieri","year":"2018","journal-title":"FASEB J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1681\/ASN.2020010031","article-title":"Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus","volume":"32","author":"Petrillo","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1681\/ASN.2012030295","article-title":"Small-molecule screening identifies modulators of aquaporin-2 trafficking","volume":"24","author":"Bogum","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2018060668","article-title":"Fluconazole increases osmotic water transport in renal collecting duct through effects on aquaporin-2 trafficking","volume":"30","author":"Hinze","year":"2019","journal-title":"J. Am. Soc. Nephrol"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41467-018-03771-2","article-title":"AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus","volume":"9","author":"Ando","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral Tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2215\/CJN.00160106","article-title":"Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist","volume":"1","author":"Soupart","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.2001","article-title":"Cardiac output improvement by pecavaptan: A novel dual-acting vasopressin V1a\/V2 receptor antagonist in experimental heart failure","volume":"23","author":"Mondritzki","year":"2021","journal-title":"Eur. J. Heart. Fail."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12950\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:37:46Z","timestamp":1760168266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":127,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222312950"],"URL":"https:\/\/doi.org\/10.3390\/ijms222312950","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}